Cargando…
Neovascular glaucoma after central retinal vein occlusion in pre-existing glaucoma
BACKGROUND: To determine the outcome of central retinal vein occlusion (CRVO) in pre-existing glaucoma and the predisposing factors of developing neovascular glaucoma (NVG). METHODS: We retrospectively assessed a pre-existing glaucoma CRVO group and a non-glaucoma CRVO group to elucidate the demogra...
Autores principales: | Chen, Hsi-Fu, Chen, Min-Chi, Lai, Chi-Chun, Yeung, Ling, Wang, Nan-Kai, Chen, Henry Shen-Lih, Ku, Wan-Chen, Wu, Shiu-Chen, Chang, Shirley H L, Chuang, Lan-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193090/ https://www.ncbi.nlm.nih.gov/pubmed/25282154 http://dx.doi.org/10.1186/1471-2415-14-119 |
Ejemplares similares
-
Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion
por: Wu, Shiu-Chen, et al.
Publicado: (2016) -
Neovascular Glaucoma Due to Branch Retinal Vein Occlusion Combined with Branch Retinal Artery Occlusion
por: An, Tae-Su, et al.
Publicado: (2013) -
Intravitreal Bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report
por: Alasil, Tarek, et al.
Publicado: (2009) -
Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion
por: Lee, You Hyun, et al.
Publicado: (2022) -
Intravitreal Bevacizumab for the Treatment of Neovascular Glaucoma Associated With Central Retinal Artery Occlusion
por: Sagong, Min, et al.
Publicado: (2009)